The Australian medical landscape is buzzing with the introduction of retatrutide, a novel dual GIP and GLP-1 receptor showing impressive results in clinical trials for treating obesity. This medication https://worldlistpro.com/story23865374/retatrutide-australia-australia-a-new-solution-for-weight-loss